TY - JOUR
T1 - In vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins
AU - Horvatovich, Péter
AU - Végvári, Ákos
AU - Saul, Justin
AU - Park, Jin
AU - Qiu, Ji
AU - Syring, Michael
AU - Pirrotte, Patrick
AU - Petritis, Konstantinos
AU - Tegeler, Tony
AU - Aziz, Meraj
AU - Fuentes, Manuel
AU - Diez, Paula
AU - Gonzalez-Gonzalez, Maria
AU - Ibarrola, Nieves
AU - Droste, Conrad
AU - De Las Rivas, Javier
AU - Gil, Concha
AU - Clemente, Felipe
AU - Hernaez, Maria Luisa
AU - Corrales, Fernando
AU - Nilsson, Carol
AU - Berven, Frode
AU - Bischoff, Rainer
AU - Fehniger, Thomas
AU - LaBaer, Joshua
AU - Marko-Varga, György
PY - 2015
Y1 - 2015
N2 - Approximately 18% of all human genes purported to encode proteins have not been directly evidenced at the protein level, according to the validation criteria established by neXtProt, and are considered as “missing” proteins. One of the goals of the Chromosome-Centric Human Proteome Project (C-HPP) is to identify as many of these “missing” proteins as possible in human samples using mass spectrometry-based methods. To further this goal, a consortium of C–HPP teams (chromosomes 5, 10, 16 and 19) has joined forces to devise new strategies to identify “missing” proteins by use of a cell-free in vitro transcription/translation system (IVTT). The proposed strategy employs LC-MS/MS data-dependent acquisition (DDA) and targeted selective reaction monitoring (SRM) methods to scrutinize low complexity samples derived from IVTT translation. The optimized assays are then applied to identify “missing” proteins in human cells and tissues. We describe the approach and show proof-of-concept results for development of LC-SRM assays for identification of eighteen “missing” proteins. We believe that the IVTT system, when coupled with downstream mass spectrometric identification, can be applied to identify proteins that have eluded more traditional methods of detection.
AB - Approximately 18% of all human genes purported to encode proteins have not been directly evidenced at the protein level, according to the validation criteria established by neXtProt, and are considered as “missing” proteins. One of the goals of the Chromosome-Centric Human Proteome Project (C-HPP) is to identify as many of these “missing” proteins as possible in human samples using mass spectrometry-based methods. To further this goal, a consortium of C–HPP teams (chromosomes 5, 10, 16 and 19) has joined forces to devise new strategies to identify “missing” proteins by use of a cell-free in vitro transcription/translation system (IVTT). The proposed strategy employs LC-MS/MS data-dependent acquisition (DDA) and targeted selective reaction monitoring (SRM) methods to scrutinize low complexity samples derived from IVTT translation. The optimized assays are then applied to identify “missing” proteins in human cells and tissues. We describe the approach and show proof-of-concept results for development of LC-SRM assays for identification of eighteen “missing” proteins. We believe that the IVTT system, when coupled with downstream mass spectrometric identification, can be applied to identify proteins that have eluded more traditional methods of detection.
KW - bioinformatics
KW - proteomics
KW - in vitro transcription translation system
KW - LC-MS
KW - chromosome centric human proteome project
KW - missing proteins
U2 - 10.1021/acs.jproteome.5b00486
DO - 10.1021/acs.jproteome.5b00486
M3 - Article
C2 - 26155874
SN - 1535-3893
VL - 14
SP - 3441
EP - 3451
JO - Journal of Proteome Research
JF - Journal of Proteome Research
IS - 9
ER -